Drug Design Reviews - Online (Discontinued)

Back

Resistin: A Promising Therapeutic Target for the Management of Type 2 Diabetes Mellitus? open Access plus

Volume:2   Issue: 1
Pp: 1-12
Javier Gomez-Ambrosi and Gema Fruhbeck
DOI: 10.2174/1567269053390446

Controlling Pathogenic Gram-Negative Bacteria by Interfering with Their Biofilm Formation open Access plus

Volume:2   Issue: 1
Pp: 13-33
Wolf-Rainer Abraham
DOI: 10.2174/1567269053390257

Drug Discovery: Methods for Identifying New Drug Targets open Access plus

Volume:2   Issue: 1
Pp: 35-46
Murty V. Chengalvala, Joshua E. Cottom, Linda K. Shanno and Gregory S. Kopf
DOI: 10.2174/1567269053390301

Transforming Growth Factor-Beta: A Potential New Agent for Pleurodesis open Access plus

Volume:2   Issue: 1
Pp: 47-51
Ioannis Kalomenidis, Richard W Light and Y C Gary Lee
DOI: 10.2174/1567269053390383

Sphingolipids as Emerging Drug Targets: Therapeutic Applications of Ceramide Analogs open Access plus

Volume:2   Issue: 1
Pp: 53-65
M. Wendeler, J. Wirtz and T. Kolter
DOI: 10.2174/1567269053390239

Chimeric and Promiscuous G Proteins in Drug Discovery and the Deorphanization of GPCRs open Access plus

Volume:2   Issue: 1
Pp: 66-79
David C. New and Yung H. Wong
DOI: 10.2174/1567269053390284

Cytotoxicity and Antiviral Activity of a Lignan Extracted from Larrea divaricata open Access plus

Volume:2   Issue: 1
Pp: 81-83
B. S. Konigheim, M. E. Goleniowski and M. S. Contigiani
DOI: 10.2174/1567269053390194

Epigallocatechin-3-Gallate (EGCG): A Structural Target for the Development of Potential Therapeutic Drugs Against Anti-Proliferative Diseases open Access plus

Volume:2   Issue: 1
Pp: 85-91
Shiva Prasad Potta, Michael Xavier Doss, Jürgen Hescheler and Agapios Sachinidis
DOI: 10.2174/1567269053390329

Author Index to Volume 1 open Access plus

Volume:2   Issue: 1
Pp: 93-94
Bentham Science Publishers
DOI: 10.2174/1567269053390356

Subject Index to Volume 1 open Access plus

Volume:2   Issue: 1
Pp: 95-100
Bentham Science Publishers
DOI: 10.2174/1567269053390428